Company Overview

Company name: Israel Botanicals
Description: Developer of various medical and botanical formulations intended to promote good health and raise awareness. The company’s formulations are prepared by combining cannabinoid products with botanical or fungi extracts, vitamins and minerals for the treatment of iron deficiency, bone health and fertility, enabling medical companies to get hold of biological formulations suiting their requirements.
Year founded: 2019
Parent company:
Industry: Healthcare | Group: | Code:
City: Tel Aviv
Country: Israel

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was formed as a joint venture between iCAN and Citrine Investments on August 1, 2019.
Number of active investors:
Profile last updated: 17-Feb-2020
Last known valuation:
Last known valuation date: